MedTrace Logo

Stromal Gene Expression During Pulmonary Sarcoidosis

NCT00837668 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 110

Last updated 2017-06-14

No results posted yet for this study

Summary

to determine the genetic pathways operating at the tissue level to cause granulomatous inflammation in the lungs and lymph nodes of patients with sarcoidosis. By so doing, we hope to identify unique genetic mechanisms which will aid in the diagnosis of sarcoidosis and will help us understand the pathogenesis of this poorly understood disease.

Conditions

  • Sarcoidosis

Sponsors & Collaborators

  • Ohio State University

    lead OTHER

Principal Investigators

  • Elliott Crouser, MD · Ohio State University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-04-30
Primary Completion
2012-02-29
Completion
2012-02-29

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00837668 on ClinicalTrials.gov